GLP-1 weight-loss drugs with semaglutide were associated with a lower risk of depression, anxiety, substance use disorders, and self-harm, according to a new study. View on euronews ...

Diabetes mellitus (DM) is associated with an elevated risk for dementia, with the highest risk for type 1 diabetes mellitus (T1DM), according to a study published online March 18 in Neurology. Anna M.

India's healthcare landscape will change as semaglutide patents expire in 2026, allowing over 50 generic versions to enter the market and improve access for diabetes and obesity treatment.

14 longevity diets backed by science can add 1.5-3 years to your life, with Mediterranean and plant-based patterns showing 18-24% lower mortality risk.

Kennedy Jr. has not stopped at his slogan urging people to “eat real food” to prevent disease. What ACA enrollees are cutting ...

Research suggests that improving heart health doesn't always require complicated health routines. From taking daily walks to ...

Acquisition will position embecta to participate in the rapidly expanding market for drug-delivery devices supporting generic ...

By Dr. Michael Baah BineyA young boy once had a severe throat infection. At first it looked like a simple illness. After a few days the fever settled and everyone assumed he was fine. But a few weeks ...

Embecta Corp. ("Embecta") (Nasdaq: EMBC), a global leader in diabetes care technology, today announced that it has entered into a definitive agreement ...

The meeting that Japanese Prime Minister Sanae Takaichi will have at the White House on Thursday originally seemed like a prime opportunity ...

As Novo Nordisk’s patent expires on March 20, Sun Pharma, Dr Reddy’s, Zydus and Mankind enter the market after months of preparation, setting up a race for early share in one of the world’s most ...